|
Wellness
first
Amway has made a successful foray in the world of wellness
through its division, Nutrilite. Sanker Parmeswaran,
Director Corporate Communications and Legal, Amway India Enterprise
and Chairman, Indian Direct Selling Association (IDSA) chats
with Nandini Patwardhan on the business of being healthy.
Indoco
gears up for Brazil
Indoco Remedies announced that its solid dosage facility at
Goa, Plant I has received approval from Brazilian food and
drug agency, Anvisa, marking the beginning of company's foray
into one of the most favoured pharmaceutical market in the
world.
USV's
facility at Daman secures USFDA nod
USV announced that its solid formulations facility at Daman
has received USFDA approval. The company has filed four ANDA's
in the US through Indicus Pharma, its affiliate company.
Amway
leads with Nutrilite
Nutrilite, the leading global brand of vitamins, minerals
and dietary supplements from Amway, is also the one of the
largest manufacturer of nutritional supplements.
Going
the biosimilars way….
While on the surface, the market for biosimilars may seem
very attractive, several significant obstacles seem to threaten
its smooth growth. The PricewaterhouseCoopers report on biosimilars
highlights the opportunities and hindrances anticipated for
generic companies in the long run. The Express Pharma Team
provides you with a snapshot of the report
Zydus
acquires Brazilian company
Announcing its second overseas acquisition this year, Zydus
Cadila signed an agreement to acquire 100 percent stake in
Quimica e Farmaceutica Nikkho do Brasil (Nikkho), a mid-sized,
privately held company in Brazil.
Orchid's
Cefepime gets FDA nod
Orchid Chemicals & Pharmaceuticals announced that it has
received approval from the USFDA for its ANDA for Cefepime
injection.
Glenmark
gets approval for Ondansetron
Glenmark Pharmaceuticals has received final approval from
the USFDA for its ANDAs for Ondansetron Hydrochloride (HCl)
tablets, 4mg (base), 8mg (base) and 24 mg (base) and Ondansetron
orally disintegrating tablets 4mg and 8mg.
Lilly
gives Distaclor marketing rights to Pharmalink
Eli Lilly has announced the divestiture of its premier antibiotic
brand, Distaclor (Cefaclor) to Pharmalink, a subsidiary of
the Quintiles International, effective from July 1, 2007 for
an undisclosed sum.
Bilcare
launches ACRP India Chapter
Bilcare Research has inaugurated its first academic centre,
Bilcare Research Academy, at Pune.
Products
|
